By 2050, construction's carbon footprint may double, jeopardizing climate targets. Transitioning to low-carbon materials is ...

Cancer incidence is rising around the world, but an international study is challenging the popular narrative that young people are at risk.

TSHA-102 granted Breakthrough Therapy designation by FDAFinalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month ...

This article describes how vibe coding is lowering the barrier to entry and boosting developer productivity for startups and ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced the publication online of Part 1 results from ...

Welcome back! Week 9 is in the books, and it’s time to sift through everything we just watched. This article isn’t about charts or graphs anymore — it’s about clear, actionable takeaways. My goal each ...